China SXT Pharmaceuticals (SXTC) Loans and Notes Receivables (2018 - 2022)
Historic Loans and Notes Receivables for China SXT Pharmaceuticals (SXTC) over the last 4 years, with Q1 2022 value amounting to $35509.0.
- China SXT Pharmaceuticals' Loans and Notes Receivables changed N/A to $35509.0 in Q1 2022 from the same period last year, while for Mar 2022 it was $35509.0, marking a year-over-year change of. This contributed to the annual value of $35509.0 for FY2022, which is N/A changed from last year.
- China SXT Pharmaceuticals' Loans and Notes Receivables amounted to $35509.0 in Q1 2022.
- Over the past 5 years, China SXT Pharmaceuticals' Loans and Notes Receivables peaked at $303379.0 during Q1 2018, and registered a low of $17744.0 during Q1 2020.
- For the 4-year period, China SXT Pharmaceuticals' Loans and Notes Receivables averaged around $101680.2, with its median value being $80054.0 (2019).
- Per our database at Business Quant, China SXT Pharmaceuticals' Loans and Notes Receivables plummeted by 1553.23% in 2019 and then tumbled by 7816.53% in 2020.
- Quarter analysis of 4 years shows China SXT Pharmaceuticals' Loans and Notes Receivables stood at $93341.0 in 2018, then dropped by 15.53% to $78843.0 in 2019, then plummeted by 77.49% to $17744.0 in 2020, then skyrocketed by 100.12% to $35509.0 in 2022.
- Its Loans and Notes Receivables was $35509.0 in Q1 2022, compared to $17744.0 in Q1 2020 and $78843.0 in Q3 2019.